Literature DB >> 27382020

A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain.

Christian González-Rivera1, Anne M Campbell2, Stacey A Rutherford1, Tasia M Pyburn3, Nora J Foegeding3, Theresa L Barke1, Benjamin W Spiller4, Mark S McClain2, Melanie D Ohi3, D Borden Lacy5, Timothy L Cover6.   

Abstract

Helicobacter pylori secretes a pore-forming VacA toxin that has structural features and activities substantially different from those of other known bacterial toxins. VacA can assemble into multiple types of water-soluble flower-shaped oligomeric structures, and most VacA activities are dependent on its capacity to oligomerize. The 88-kDa secreted VacA protein can undergo limited proteolysis to yield two domains, designated p33 and p55. The p33 domain is required for membrane channel formation and intracellular toxic activities, and the p55 domain has an important role in mediating VacA binding to cells. Previous studies showed that the p55 domain has a predominantly β-helical structure, but no structural data are available for the p33 domain. We report here the purification and analysis of a nonoligomerizing mutant form of VacA secreted by H. pylori The nonoligomerizing 88-kDa mutant protein retains the capacity to enter host cells but lacks detectable toxic activity. Analysis of crystals formed by the monomeric protein reveals that the β-helical structure of the p55 domain extends into the C-terminal portion of p33. Fitting the p88 structural model into an electron microscopy map of hexamers formed by wild-type VacA (predicted to be structurally similar to VacA membrane channels) reveals that p55 and the β-helical segment of p33 localize to peripheral arms but do not occupy the central region of the hexamers. We propose that the amino-terminal portion of p33 is unstructured when VacA is in a monomeric form and that it undergoes a conformational change during oligomer assembly.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27382020      PMCID: PMC4995914          DOI: 10.1128/IAI.00254-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  69 in total

1.  Mutational analysis of the Helicobacter pylori vacuolating toxin amino terminus: identification of amino acids essential for cellular vacuolation.

Authors:  D Ye; S R Blanke
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin.

Authors:  V Q Nguyen; R M Caprioli; T L Cover
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin.

Authors:  D Ye; D C Willhite; S R Blanke
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

4.  Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells.

Authors:  M S McClain; W Schraw; V Ricci; P Boquet; T L Cover
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

5.  VacA from Helicobacter pylori: a hexameric chloride channel.

Authors:  H Iwamoto; D M Czajkowsky; T L Cover; G Szabo; Z Shao
Journal:  FEBS Lett       Date:  1999-04-30       Impact factor: 4.124

6.  The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH.

Authors:  D M Czajkowsky; H Iwamoto; T L Cover; Z Shao
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release.

Authors:  A Galmiche; J Rassow; A Doye; S Cagnol; J C Chambard; S Contamin; V de Thillot; I Just; V Ricci; E Solcia; E Van Obberghen; P Boquet
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

8.  3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin.

Authors:  J M Reyrat; S Lanzavecchia; P Lupetti; M de Bernard; C Pagliaccia; V Pelicic; M Charrel; C Ulivieri; N Norais; X Ji; V Cabiaux; E Papini; R Rappuoli; J L Telford
Journal:  J Mol Biol       Date:  1999-07-09       Impact factor: 5.469

9.  A dominant negative mutant of Helicobacter pylori vacuolating toxin (VacA) inhibits VacA-induced cell vacuolation.

Authors:  A D Vinion-Dubiel; M S McClain; D M Czajkowsky; H Iwamoto; D Ye; P Cao; W Schraw; G Szabo; S R Blanke; Z Shao; T L Cover
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

10.  Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity.

Authors:  I Szabò; S Brutsche; F Tombola; M Moschioni; B Satin; J L Telford; R Rappuoli; C Montecucco; E Papini; M Zoratti
Journal:  EMBO J       Date:  1999-10-15       Impact factor: 11.598

View more
  11 in total

Review 1.  While the revolution will not be crystallized, biochemistry reigns supreme.

Authors:  Yoshimasa Takizawa; Elad Binshtein; Amanda L Erwin; Tasia M Pyburn; Kathleen F Mittendorf; Melanie D Ohi
Journal:  Protein Sci       Date:  2016-10-06       Impact factor: 6.725

2.  A Helicobacter pylori Vacuolating Cytotoxin A: Mouse DHFR Fusion Protein Triggers Dye Release from Liposomes.

Authors:  Aung Khine Linn; Nitchakan Samainukul; Somsri Sakdee; Chanan Angsuthanasombat; Gerd Katzenmeier
Journal:  Curr Microbiol       Date:  2017-10-14       Impact factor: 2.188

3.  Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA.

Authors:  Krishnan Raghunathan; Nora J Foegeding; Anne M Campbell; Timothy L Cover; Melanie D Ohi; Anne K Kenworthy
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

4.  Intracellular Degradation of Helicobacter pylori VacA Toxin as a Determinant of Gastric Epithelial Cell Viability.

Authors:  Nora J Foegeding; Krishnan Raghunathan; Anne M Campbell; Sun Wook Kim; Ken S Lau; Anne K Kenworthy; Timothy L Cover; Melanie D Ohi
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

5.  Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization.

Authors:  Min Su; Amanda L Erwin; Anne M Campbell; Tasia M Pyburn; Lauren E Salay; Jessica L Hanks; D Borden Lacy; David L Akey; Timothy L Cover; Melanie D Ohi
Journal:  J Mol Biol       Date:  2019-04-05       Impact factor: 5.469

6.  Functional Properties of Oligomeric and Monomeric Forms of Helicobacter pylori VacA Toxin.

Authors:  Georgia C Caso; Mark S McClain; Amanda L Erwin; Mandy D Truelock; Anne M Campbell; Catherine S Leasure; Marcus Nagel; Kevin L Schey; D Borden Lacy; Melanie D Ohi; Timothy L Cover
Journal:  Infect Immun       Date:  2021-09-20       Impact factor: 3.441

7.  Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants.

Authors:  Rhonda R Caston; Johanna C Sierra; Nora J Foegeding; Mandy D Truelock; Anne M Campbell; Arwen E Frick-Cheng; Diane Bimczok; Keith T Wilson; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

8.  Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells.

Authors:  Andreas Kyburz; Angela Fallegger; Xiaozhou Zhang; Aleksandra Altobelli; Mariela Artola-Boran; Timothy Borbet; Sabine Urban; Petra Paul; Christian Münz; Stefan Floess; Jochen Huehn; Timothy L Cover; Martin J Blaser; Christian Taube; Anne Müller
Journal:  J Allergy Clin Immunol       Date:  2018-09-19       Impact factor: 10.793

Review 9.  Pleiotropic cytotoxicity of VacA toxin in host cells and its impact on immunotherapy.

Authors:  Farnaz Fahimi; Mohammad Reza Tohidkia; Mehdi Fouladi; Reza Aghabeygi; Naser Samadi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2017-03-30

Review 10.  Helicobacter pylori Vacuolating Toxin and Gastric Cancer.

Authors:  Mark S McClain; Amber C Beckett; Timothy L Cover
Journal:  Toxins (Basel)       Date:  2017-10-12       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.